How to characterize and treat sleep complaints in bipolar disorders?;Comment caractériser et traiter les plaintes de sommeil dans les troubles bipolaires ?

Encephale

Volumn 43, Issue 4, 2017, Pages 363-373

  Geoffroy, P A ^a,b,c,d   Micoulaud Franchi, J A ^e,f   Lopez, R ^a,g   Poirot, I ^h   Brion, A ⁱ   Royant Parola, S ^i,j   Etain, B ^a,b,c,d  

^a INSERM   (France)

^b UMR S 1144   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d FONDATION FONDAMENTAL   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g GUI DE CHAULIAC HOSPITAL   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ Réseau MORPHEE   (France)

^j Clinique du Chateau   (France)

more..

Author keywords

Bipolar disorders; Circadian rhythms; Hypersomnia; Insomnia; Sleep

Indexed keywords

HYPNOTIC AGENT;

APNEA; ARTICLE; BIPOLAR DISORDER; CIRCADIAN RHYTHM; COMORBIDITY; HUMAN; HYPERSOMNIA; INSOMNIA; MAJOR DEPRESSION; MANIA; PSYCHOTHERAPY; QUALITY OF LIFE; REMISSION; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP PATTERN; SLEEP PHASE DELAY SYNDROME; SLEEP TIME; SLEEP WAKING CYCLE; SOMNOLENCE; SUICIDAL BEHAVIOR; WEIGHT GAIN; COMPLICATION; META ANALYSIS; PATHOPHYSIOLOGY; PSYCHOLOGY;

BIPOLAR DISORDER; CIRCADIAN RHYTHM; HUMANS; SLEEP WAKE DISORDERS;

EID: 84995598381     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2016.06.007     Document Type: Article

References (59)

1. Merikangas, K.R., Akiskal, H.S., Angst, J., et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64:5 (2007), 543–552.
2. Geoffroy, P.A., Etain, B., Leboyer, M., et al. A clinical entity with major therapeutic implication: the early onset bipolar disorder. Ann Med Psychol Rev Psychiatr 170:7 (2012), 502–509.
3. Leboyer, M., Kupfer, D.J., Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry 71:12 (2010), 1689–1695.
4. Collins, P.Y., Patel, V., Joestl, S.S., et al. Grand challenges in global mental health. Nature 475:7354 (2011), 27–30.
5. Geoffroy, P.A., Etain, B., Jamain, S., et al. [Early onset bipolar disorder: validation from admixture analyses and biomarkers]. Can J Psychiatry Rev Can Psychiatr 58:4 (2013), 240–248.
6. Whiteford, H.A., Degenhardt, L., Rehm, J., et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382:9904 (2013), 1575–1586.
7. Geoffroy, P.A., Scott, J., Boudebesse, C., et al. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand 131:2 (2015), 89–99.
8. Etain, B., Milhiet, V., Bellivier, F., et al. Genetics of circadian rhythms and mood spectrum disorders. Eur Neuropsychopharmacol 21:Suppl. 4 (2011), S676–S682.
9. Bellivier, F., Geoffroy, P.-A., Etain, B., et al. Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorder. Expert Opin Ther Targets, 2015, 1–17.
10. McClung, C.A., How might circadian rhythms control mood? Let me count the ways. Biol Psychiatry 74:4 (2013), 242–249.
11. Harvey, A.G., Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 165:7 (2008), 820–829.
12. Hickie, I.B., Rogers, N.L., Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet Lond Engl 378:9791 (2011), 621–631.
13. McClung, C.A., Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 114:2 (2007), 222–232.
14. Rocha, P.M.B., Neves, F.S., Corrêa, H., Significant sleep disturbances in euthymic bipolar patients. Compr Psychiatry 54:7 (2013), 1003–1008.
15. Sylvia, L.G., Dupuy, J.M., Ostacher, M.J., et al. Sleep disturbance in euthymic bipolar patients. J Psychopharmacol Oxf Engl 26:8 (2012), 1108–1112.
16. Kaplan, K.A., Gruber, J., Eidelman, P., et al. Hypersomnia in inter-episode bipolar disorder: does it have prognostic significance?. J Affect Disord 132:3 (2011), 438–444.
17. Jackson, A., Cavanagh, J., Scott, J., A systematic review of manic and depressive prodromes. J Affect Disord 74:3 (2003), 209–217.
18. Geoffroy, P.A., Etain, B., Sportiche, S., et al. Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response. Int J Bipolar Disord, 2(1), 2014, 5.
19. Scott, J., Clinical parameters of circadian rhythms in affective disorders. Eur Neuropsychopharmacol 21:Suppl. 4 (2011), S671–S675.
20. Geoffroy, P.A., Scott, J., Boudebesse, C., et al. Sleep in patients with remitted bipolar disorders: analyses stratified on actigraphy devices, age and gender. Acta Psychiatr Scand, 131(5), 2015, 400.
21. ICSD-3 Online Version – American Academy of sleep medicine (AASM) [Internet]. 2016, AASM http://www.aasmnet.org/store/product.aspx?pid=849.
22. Ng, T.H., Chung, K.-F., Ho, F.Y.-Y., et al. Sleep-wake disturbance in interepisode bipolar disorder and high-risk individuals: a systematic review and meta-analysis. Sleep Med Rev, 131(5), 2014, 400.
23. Harvey, A.G., Schmidt, D.A., Scarnà, A., et al. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry 162:1 (2005), 50–57.
24. Steinan, M.K., Scott, J., Lagerberg, T.V., et al. Sleep problems in bipolar disorders: more than just insomnia. Acta Psychiatr Scand 133:5 (2015), 368–377.
25. Henry, C., Etain, B., Godin, O., et al. Bipolar patients referred to specialized services of care: Not resistant but impaired by sub-syndromal symptoms. Results from the FACE-BD cohort. Aust N Z J Psychiatry 49:10 (2015), 898–905.
26. Young, T., Palta, M., Dempsey, J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:17 (1993), 1230–1235.
27. Kelly, T., Douglas, L., Denmark, L., et al. The high prevalence of obstructive sleep apnea among patients with bipolar disorders. J Affect Disord 151:1 (2013), 54–58.
28. Geoffroy, P.A., Boudebesse, C., Bellivier, F., et al. Sleep in remitted bipolar disorder: a naturalistic case-control study using actigraphy. J Affect Disord 158 (2014), 1–7.
29. Steinan, M.K., Morken, G., Lagerberg, T.V., et al. Delayed sleep phase: an important circadian subtype of sleep disturbance in bipolar disorders. J Affect Disord 191 (2016), 156–163.
30. Nurnberger, J.I. Jr., Adkins, S., Lahiri, D.K., et al. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry 57:6 (2000), 572–579.
31. Nurnberger, J.I. Jr., Berrettini, W., Tamarkin, L., et al. Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacol 1:3 (1988), 217–223.
32. Kennedy, S.H., Kutcher, S.P., Ralevski, E., et al. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res 63:2–3 (1996), 219–222.
33. McIntyre, I.M., Norman, T.R., Burrows, G.D., et al. Human melatonin suppression by light is intensity dependent. J Pineal Res 6:2 (1989), 149–156.
34. Hallam, K.T., Olver, J.S., Chambers, V., et al. The heritability of melatonin secretion and sensitivity to bright nocturnal light in twins. Psychoneuroendocrinology 31:7 (2006), 867–875.
35. Pacchierotti, C., Iapichino, S., Bossini, L., et al. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol 22:1 (2001), 18–32.
36. Phillips, B., Young, T., Finn, L., et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 160:14 (2000), 2137–2141.
37. Becker, P.M., The biopsychosocial effects of restless legs syndrome (RLS). Neuropsychiatr Dis Treat 2:4 (2006), 505–512.
38. Banno, Delaive, Walld, et al. Restless legs syndrome in 218 patients: associated disorders. Sleep Med 1:3 (2000), 221–229.
39. Cretu, J.B., Culver, J.L., Goffin, K.C., et al. Sleep, residual mood symptoms, and time to relapse in recovered patients with bipolar disorder. J Affect Disord 190 (2016), 162–166.
40. Perlis, R.H., Dennehy, E.B., Miklowitz, D.J., et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord 11:4 (2009), 391–400.
41. Perlis, R.H., Ostacher, M.J., Patel, J.K., et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 163:2 (2006), 217–224.
42. Boland, E.M., Alloy, L.B., Sleep disturbance and cognitive deficits in bipolar disorder: toward an integrated examination of disorder maintenance and functional impairment. Clin Psychol Rev 33:1 (2013), 33–44.
43. Russo, M., Mahon, K., Shanahan, M., et al. The relationship between sleep quality and neurocognition in bipolar disorder. J Affect Disord 187 (2015), 156–162.
44. Volkert, J., Kopf, J., Kazmaier, J., et al. Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances. Eur Neuropsychopharmacol 25:2 (2015), 192–202.
45. Rosa, A.R., Comes, M., Torrent, C., et al. Biological rhythm disturbance in remitted bipolar patients. Int J Bipolar Disord, 1, 2013, 6.
46. Godin, O., Etain, B., Henry, C., et al. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort. J Clin Psychiatry 75:10 (2014), 1078–1085 [quiz 1085].
47. Vancampfort, D., Stubbs, B., Mitchell, A.J., et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14:3 (2015), 339–347.
48. Boudebesse, C., Geoffroy, P.-A., Henry, C., et al. Links between sleep and body mass index in bipolar disorders: an exploratory study. Eur Psychiatry J Assoc Eur Psychiatr 30:1 (2014), 89–93.
49. Soreca, I., Wallace, M.L., Frank, E., et al. Sleep duration is associated with dyslipidemia in patients with bipolar disorder in clinical remission. J Affect Disord 141:2–3 (2012), 484–487.
50. Benard, V., Geoffroy, P.A., Bellivier, F., [Seasons, circadian rhythms, sleep and suicidal behaviors vulnerability]. Encéphale 41:4 Suppl. 1 (2015), S29–S37.
51. Saxvig, I.W., Wilhelmsen-Langeland, A., Pallesen, S., et al. A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: effects on subjective and objective sleep. Chronobiol Int 31:1 (2014), 72–86.
52. Karroum, E., Konofal, E., Arnulf, I., [Restless-legs syndrome]. Rev Neurol (Paris) 164:8–9 (2008), 701–721.
53. Haute Autorité de Santé. Quelle place pour les agonistes dopaminergiques dans le syndrome des jambes sans repos ? – Fiche BUM [Internet]. [cité 25 févr 2016]. Disponible sur : http://www.has-sante.fr/portail/jcms/c_1736412/fr/quelle-place-pour-les-agonistes-dopaminergiques-dans-le-syndrome-des-jambes-sans-repos-fiche-bum.
54. Morin, C.M., Vallières, A., Guay, B., et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA 301:19 (2009), 2005–2015.
55. Harvey, A.G., Soehner, A.M., Kaplan, K.A., et al. Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial. J Consult Clin Psychol 83:3 (2015), 564–577.
56. Kaplan, K.A., Harvey, A.G., Behavioral treatment of insomnia in bipolar disorder. Am J Psychiatry 170:7 (2013), 716–720.
57. Bottai, T., Biloa-Tang, M., Christophe, S., et al. [Interpersonal and social rhythm therapy (IPSRT)]. Encéphale 36:Suppl. 6 (2010), S206–S217.
58. Anderson, G., Jacob, A., Bellivier, F., et al. Bipolar disorder: the role of the kynurenine and melatonergic pathways. Curr Pharm Des 22:8 (2015), 987–1012.
59. Geoffroy, P.A., Etain, B., Franchi J-AM, et al. Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders. Curr Pharm Des 21:23 (2015), 3352–3358.